What is a TIF Procedure?

A TIF Procedure, or transoral incisionless fundoplication, is a simple intervention that repairs the gastroesophageal valve without surgery and treats conditions like acid reflux or GERD.

Benefits & Risks

The TIF procedure is a safe, minimally invasive procedure to solve reflux. Most patients can return home the same or following day and can resume most ordinary activities within a few days.

As with any procedure or treatment, side effects can occur. Please discuss any possible side effects with your doctor.

What to Expect

You will be given specific instructions to prepare for your TIF procedure.

Before your procedure, you will need to have an empty stomach. Your physician will request that you don’t eat or drink after midnight on the day of your procedure. Additionally, if you take any blood-thinning medication, your physician may request that you stop using for 3-5 days before the test.

The TIF procedure is performed under general anesthesia and takes less than an hour. During the procedure, your doctor will guide an EsophyX device with an endoscope through the mouth, esophagus, and into the stomach. The EsophyX device reconstructs the antireflux valve by wrapping the upper portion of the stomach (fundus) around the damaged lower portion of the esophagus. It's then secured with polypropylene fasteners (fundoplication). Your doctor will leave fasteners in place to secure the newly constructed valve while you heal. There’s no need to remove them as the body heals around them.

After the procedure, expect minor discomfort in the shoulder, stomach, chest, nose, or throat for up to seven days. Your doctor can prescribe medications for pain and nausea management. Your doctor will also typically recommend following a modified diet and limited activity.

Learn more about TIF Procedure

Men and Esophageal Cancer

According to the Salgi Esophageal Cancer Research Foundation, esophageal cancer is among the fastest growing and deadliest cancers in the United States. Statistically, men are 3 to 4 times more likely than women to be diagnosed with esophageal cancer.

Read Article